H.R. 5958 · 118th Congress · House

Drug-price Transparency for Consumers Act of 2023

Active· Referred to the Subcommittee on Health.
Introduced
Oct 13, 23
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Action Timeline

5
  1. DEC 17, 2024Committee

    Referred to the Subcommittee on Health.

  2. OCT 25, 2023IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  3. OCT 25, 2023IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  4. OCT 13, 2023IntroReferral

    Introduced in House

  5. OCT 13, 2023IntroReferral

    Introduced in House

Committees

3

Health Subcommittee

hswm02

Referred: Dec 17, 2024

Active

Ways and Means Committee

hswm00

Referred: Oct 25, 2023

Active

Energy and Commerce Committee

hsif00

Referred: Oct 25, 2023

Active